$2.26 +0.03 (1.35%) Rigel Pharmaceuticals Inc - NASDAQ

Jul. 22, 2016 | 04:00 PM

Charts

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Key Statistics
Last Trade: 2.26
Trade Time: Jul 22 04:00 PM Eastern Daylight Time
Change: +0.03 (1.35%)
Prev Close: 2.23
Open: 2.27
Bid: 2.25
Ask: 2.26

Competitors

Ticker Name Volume % Change
AZN AstraZeneca Shs Sponsored American Deposit Share Repr 1/2 Sh 12.32M +1.97%
BMY Bristol-Myers Squibb Co 5.28M +0.24%
CELG Celgene Corp 3.48M +0.07%
IRWD Ironwood Pharmaceuticals Inc 828.11K +3.11%
INVA Innoviva Inc 506.90K -0.09%

RIGL Stock Analysis

  1. No results found.

Partner Headlines

  1. Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP

    Benzinga | Jan. 28, 2016 | 07:37AM EST
  2. Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

    Benzinga | Sep. 8, 2015 | 07:30AM EST
  3. Earnings Scheduled For March 3, 2015

    Benzinga | Mar. 3, 2015 | 04:18AM EST
  4. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  5. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  6. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST